Drugs News and Research

RSS

Illicit drug use is higher during celebratory events, may be worse than previously thought

America's drug problem may be even worse than officials realize. And illicit drugs are consumed at a higher rate during celebratory events. Those are just two of the conclusions scientists have drawn from recent studies of drug residues in sewage.

20 Aug 2018

New drug shows potential to prevent painful side effect of therapy

About 50,000 people in the U.S. are diagnosed annually with head, neck, nasal and oral cancers. Most are treated with radiation, and of those, 70-80 percent develop a painful and debilitating side effect called severe oral mucositis.

20 Aug 2018

The man who sold America on vitamin D — and profited in the process

Dr. Michael Holick's enthusiasm for vitamin D can be fairly described as extreme.

20 Aug 2018

Babies dependent on opioids need touch, not tech

Dr. Jodi Jackson has worked for years to address infant mortality in Kansas. Often, that means she treats newborns in a high-tech neonatal intensive care unit with sophisticated equipment whirring and beeping. And that is exactly the wrong place for an infant like Lili.

20 Aug 2018

Understanding How Antibodies Shape the Gut Microbiome

Dr. Keiichiro Suzuki discusses the importance of IgA in the human body, and his recent research study, which showed that IgA interacts with the gut microbiome and promotes the growth of healthy bacteria.

20 Aug 2018

Harbour Biomed and Kelun-Biotech collaborate to develop, commercialize anti-PD-L1 antibody

Harbour BioMed today announced it has entered into an exclusive strategic partnership with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. to develop and commercialize A167, an anti-PD-L1 antibody in Phase 2 clinical development, worldwide outside of the Greater China region.

20 Aug 2018

Novel system can pinpoint ingestible implants inside the body using wireless signals

Medical processes like imaging often require cutting someone open or making them swallow huge tubes with cameras on them. But what if could get the same results with methods that are less expensive, invasive and time-consuming?

20 Aug 2018

URI professor develops simpler and quicker method for detecting impurity in heparin

In 2008, a contaminant eluded the quality safeguards in the pharmaceutical industry and infiltrated a large portion of the supply of the popular blood thinner heparin, sickening hundreds and killing about 100 in the U.S.

19 Aug 2018

Loyola Medicine offers scalp cooling treatment to reduce risk of chemotherapy hair loss

Loyola Medicine is offering cancer patients a treatment that reduces the risk of hair loss by cooling the scalp.

18 Aug 2018

HSS takes young patients with physical challenges on a surfing trip

Hospital for Special Surgery made a splash this week with a surfing trip for young patients. Giving new meaning to the term "patient care," the Adaptive Sports Academy at Lerner Children's Pavilion at HSS treated 12 patients, along with some of their siblings, to sand and surf in Long Beach, Long Island.

17 Aug 2018

New statewide program in North Dakota aims to stem opioid misuse

Preliminary estimates released by the U.S. Centers for Disease Control and Prevention show a nearly 7 percent increase in drug overdoses in 2017, with more than 72,000 deaths. Of the total deaths, almost 68 percent of them were tied to opioid use. A new statewide program in North Dakota called ONE Rx aims to stem opioid misuse by increasing awareness when patients first fill an opioid prescription.

17 Aug 2018

New modeling studies highlight urgent need for effective drug policy reforms to prevent HIV

While global incidence rates of HIV have declined notably in recent years, the virus that causes AIDS remains a major and, in some ways largely unmitigated, public health threat in some countries and regions.

17 Aug 2018

Body mass index positively linked with blood pressure

Body mass index is positively associated with blood pressure, according to the ongoing study of 1.7 million Chinese men and women being conducted by researchers at the Yale Center for Outcomes Research and Evaluation and in China.

17 Aug 2018

Study compares survival outcomes in rural and urban cancer patients enrolled in clinical trials

When enrolled in a cancer clinical trial, the differences in survival rates between rural and urban patients are significantly reduced, SWOG study results show.

17 Aug 2018

Shortage of insurance fraud cops sparks campaign debate

Ask Steve Poizner about how he'll tackle health care costs if he recaptures his old job as California's insurance commissioner, and he has a ready example.

17 Aug 2018

Sunscreen from bathers releases significant quantities of polluting titanium dioxide into the sea

Scientists have found that sunscreen from bathers releases significant quantities of polluting TiO2 (titanium dioxide) into the sea.

17 Aug 2018

FDA approves marketing of brainsway deep transcranial magnetic stimulation system for OCD

Today, the U.S. Food and Drug Administration permitted marketing of the Brainsway Deep Transcranial Magnetic Stimulation System for treatment of obsessive compulsive disorder (OCD).

17 Aug 2018

Innovative platform developed to destroy cancer cells

The new treatment will serve as both diagnosis and treatment of malignant tumors. This breakthrough in the technologies of cancer diagnosis and treatment was made by an interdisciplinary Russian-German collaboration of chemists, physicists, and biologists from NUST MISIS, Lomonosov Moscow State University, Pirogov Russian National Research Medical University (RNRMU), and the University of Duisburg-Essen (Germany).

17 Aug 2018

Researchers discuss techniques to help combat growing epidemic of obesity

More than 60 percent of American adults weigh more than is healthy, which results in increased health issues for the patient and high health care costs.

17 Aug 2018

Ology Bioservices wins $8.4 million worth agreement to manufacture anti-Ebola monoclonal antibody

Ology Bioservices, Inc., a biologics contract development and manufacturing organization, announced today that it was awarded an Other Transaction Agreement to support the Joint Project Manager Medical Countermeasure Systems, a component of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense for advanced biologics manufacturing services—specifically, to manufacture an anti-Ebola monoclonal antibody.

17 Aug 2018

Drugs News and Research

Illicit drug use is higher during celebratory events, may be worse than previously thought

New drug shows potential to prevent painful side effect of therapy

The man who sold America on vitamin D — and profited in the process

Babies dependent on opioids need touch, not tech

Understanding How Antibodies Shape the Gut Microbiome

Harbour Biomed and Kelun-Biotech collaborate to develop, commercialize anti-PD-L1 antibody

Novel system can pinpoint ingestible implants inside the body using wireless signals

URI professor develops simpler and quicker method for detecting impurity in heparin

Loyola Medicine offers scalp cooling treatment to reduce risk of chemotherapy hair loss

HSS takes young patients with physical challenges on a surfing trip

New statewide program in North Dakota aims to stem opioid misuse

New modeling studies highlight urgent need for effective drug policy reforms to prevent HIV

Body mass index positively linked with blood pressure

Study compares survival outcomes in rural and urban cancer patients enrolled in clinical trials

Shortage of insurance fraud cops sparks campaign debate

Sunscreen from bathers releases significant quantities of polluting titanium dioxide into the sea

FDA approves marketing of brainsway deep transcranial magnetic stimulation system for OCD

Innovative platform developed to destroy cancer cells

Researchers discuss techniques to help combat growing epidemic of obesity

Ology Bioservices wins $8.4 million worth agreement to manufacture anti-Ebola monoclonal antibody

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News